on-line

On-line Education Teaches on Massive and Sub-massive Pulmonary Emboli

by

OSUWexnerbloglogo2014On-line Education Teaches on Massive and Sub-massive Pulmonary Emboli. Despite the availability of newer and safer anticoagulants, people still die from pulmonary embolism. But we now have new treatments that can offer hope to those patients with the most life-threatening pulmonary emboli. Here to update us is cardiologist and Assistant Professor of Internal Medicine, Dr. Cindy Baker.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS risk stratification of patients presenting with pulmonary embolus; and REVIEW pharmacologic, percutaneous and surgical options for pulmonary embolus.

You’ll also learn about the following:

  • New developments
  • Role on the amount of clot seen on CT scan in clinical decision making
  • Post-treatment follow-up

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Provides Understanding of Suboxone Treatment

by

OSUWexnerbloglogo2014 On-line Education Provides Understanding of Suboxone Treatment. On this CME webcast, we are going to examine how buprenorphine and Suboxone fit into the management of the opioid-addicted patient in the hospital. To tell us how this works in the emergency department is Assistant Professor of Internal Medicine and Emergency Medicine, Dr. Emily Kauffman. And to tell us about medication assisted treatment for inpatients is hospitalist and Assistant Professor of Internal Medicine, Dr. Margaret Williams.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: EXPLAIN why Medications-Assisted Treatment (MAT), specifically buprenorphine (suboxone) is effective for treatment of Opioid Use Disorder; DESCRIBE the importance of addressing opioid use disorder in all patient encounters, beginning with the Emergency Department.

You’ll also learn about the following:

  • The role of the emergency department in treating opioid addiction
  • The role of medication assisted therapy in hospitalized patients
  • Project DAWN
  • RREACT
  • Management of opioid-dependent patients who are NPO
  • DEA-X waivers

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About E-Cigarettes

by

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About E-Cigarettes. On this CME webcast, we’re going to be examining e-cigarettes, what they are, how they can affect one’s health, and what their role is in smoking cessation. Joining us today is pulmonologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Joanna Tsai. And also, tobacco treatment specialist and pulmonary nurse practitioner from Ohio State, Gretchen Whitby.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND what an e-cigarette is and what it is composed of; IDENTIFY potential risks with e-cigarette use; LIST two pros and two cons of e-cigarette usage for current e-cigarette users ; and DESCRIBE two reasons to recommend FDA approved smoking cessation medications over e-cigarette usage to help your patients quit.

You’ll also learn about the following:

  • E-cigarettes and vaping
  • Nicotine and breast milk
  • Nicotine poisoning
  • E-cigarettes and home oxygen use
  • E-cigarette use in public areas
  • Diacetyl and e-cigarettes
  • Medications used in tobacco treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Webcast Discusses Obstructive Sleep Apnea

by

OSUWexnerbloglogo2014 On-line Webcast Discusses Obstructive Sleep Apnea. Obstructive sleep apnea is incredibly common and destined to only become more common in the future. On this CME webcast, we are going to learn about the diagnosis and treatment of sleep apnea. Joining us today are sleep medicine specialists from the Ohio State University. Dr. Steven Holfinger is an Assistant Professor of Internal Medicine and Dr. Madelyn Rosenthal is also an Assistant Professor of Internal Medicine, both from the Division of Pulmonary, Critical Care, and Sleep Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: APPROPRIATELY screen patients in a primary care setting; DIAGNOSE sleep apnea with appropriate testing; UNDERSTAND the important factors that should be addressed at each obstructive sleep apnea follow up visit; and RECOGNIZE and troubleshoot common factors that affect PAP adherence, residual daytime sleepiness and nasal congestion.

You’ll also learn about the following:

  • Sleep apnea risk factors
  • Pre-operative screening for obstructive sleep apnea
  • Mask options
  • Dental devices and surgery for obstructive sleep apnea
  • Management of central sleep apnea
  • Auto-CPAP machines
  • The economics of CPAP equipment
  • Treatment of snoring

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Webcast Discusses Chronic Lymphocytic Leukemia

by

OSUWexnerbloglogo2014 On-line Webcast Discusses Chronic Lymphocytic Leukemia. On this CME webcast, we’re going to bring you up to date on the latest about chronic lymphocytic leukemia, or CLL. Joining us is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Kerry Rogers. And also hematologist and Associate Professor of Internal Medicine from OSU and the James Cancer Hospital, Dr. Jennifer Woyach.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CLL is a chronic lymphoid malignancy which does not need treatment at diagnosis if asymptomatic and has a survival of many years; CLL patients are at higher risk for second cancers or infection so it is important so all CLL patients with CLL should get all age appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait approach; and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL.

You’ll also learn about the following:

  • Risks for CLL
  • Current approach to treatment of CLL
  • Roles and limitations of automated WBC differentials
  • Initial approach to lymphocytosis
  • Emerging trends in first line treatment of CLL
  • Role of age of the patient in therapeutic decision making
  • Stem cell transplants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.